Patent · US Active

Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein

US9695187B2 · kind B2 · utility

1Cited by
2References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2016
Grant dateJul 4, 2017
Priority date
Expiry dateFeb 4, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, R7, R7′, R8, R9, R10, R11, R12 and R13 are as disclosed herein. Also, disclosed is a process for the preparation of the compound of formula 1, or a pharmaceutically acceptable salt thereof, and intermediates used therein. The compound of formula 1 can be used in the preparation of halichondrin analogs, such as Eribulin; and a process for its preparation from the compound of formula 1 is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.